Etubics Corporationbased In Seattlewash Is A Next Generation Clinical Stagebio Pharmaceutical Companythecompany Is Developing Thenext Generation In Vaccines And Immunotherapiesutilizing A Patented Advanced Generation Adenovirus Delivery Platform And A Validated Manufacturing Human Cell Linecollectively Theetubics Platformthecompany S Products Havebeen Developed To Overcomethreesignificant Limitations Associated With Existing Adenovirus Based Productsiineffectiveness In Thepresenceof Preexisting Immunityiiinability To Immunizemultipletimes Against Thesamediseaseandiiiinability To Immunizeagainst Multiplediseases In Thesamepersonbenefits Of Theetubics Platform Products Includethefollowing Aecsafeand Thoroughly Studied Including Human Trialsaeceffectivein Thepresenceof Preexisting Immunityaeccmi Responseaecrapid Developmentaecdiverseproduct Opportunitiesthecompany Has Completed Phasei Iia Clinical Trials With Its Lead Productetbx 011 An Immunotherapeutic To Treat Colorectal Cancerto Datethecompany Has Been Very Encouraged By Theclinical Data For Etbx 011 And No Safety Issues Or Serious Adverseeffectssaehavebeen Reported In Both Animal And Human Studies
